Citadel Advisors
NVX

Citadel Advisors’s NOVONIX NVX Stock Holding History

Citadel Advisors’s Portfolio NVX Stock Details NVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Buy
266,401
+221,325
+491% +$215K ﹤0.01% 11496
2025
Q4 		$45.5K Sell
45,076
-64,298
-59% -$91.2K ﹤0.01% 12074
2025
Q3 		$140K Buy
109,374
+99,095
+964% +$129K ﹤0.01% 11585
2025
Q2 		$10.4K Buy
+10,279
New +$11.8K ﹤0.01% 12197
2024
Q3 		– Sell
-26,857
Closed -$48.1K – 14924
2024
Q2 		$48.1K Sell
26,857
-14,421
-35% -$32.2K ﹤0.01% 11806
2024
Q1 		$94.5K Buy
+41,278
New +$83.3K ﹤0.01% 11439

Other funds holding NVX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's NVX Position: Q1 2026 in Review

Citadel Advisors increased its NOVONIX (NVX) stake by 491% in Q1 2026, buying an estimated $215K and bringing the position to 266,401 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #11496.

Citadel Advisors first reported a position in NVX in Q1 2024 and has held it in 6 quarters since. 32 funds tracked by Wall St. Rank hold NVX as of Q1 2026.

  • Citadel Advisors held 266,401 shares of NOVONIX worth $184K as of Q1 2026.
  • Citadel Advisors bought 221,325 NOVONIX shares in Q1 2026, an estimated $215K.
  • NOVONIX made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11496 holding.
  • Citadel Advisors first reported a position in NOVONIX in Q1 2024 and has held it in 6 quarters since.
  • 32 funds tracked by Wall St. Rank held NOVONIX as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.